Human Investing’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $435K | Buy |
3,385
+107
| +3% | +$12.5K | 0.06% | 69 |
|
|
2026
Q1 | $394K | Sell |
3,278
-943
| -22% | -$109K | 0.06% | 66 |
|
|
2025
Q4 | $444K | Buy |
4,221
+217
| +5% | +$20.4K | 0.06% | 67 |
|
|
2025
Q3 | $336K | Sell |
4,004
-722
| -15% | -$59.5K | 0.05% | 73 |
|
|
2025
Q2 | $374K | Sell |
4,726
-115
| -2% | -$9.14K | 0.06% | 70 |
|
|
2025
Q1 | $435K | Sell |
4,841
-426
| -8% | -$39.8K | 0.08% | 61 |
|
|
2024
Q4 | $524K | Sell |
5,267
-503
| -9% | -$51.9K | 0.09% | 58 |
|
|
2024
Q3 | $655K | Buy |
5,770
+200
| +4% | +$23.8K | 0.12% | 52 |
|
|
2024
Q2 | $690K | Sell |
5,570
-38
| -0.7% | -$4.89K | 0.13% | 45 |
|
|
2024
Q1 | $740K | Sell |
5,608
-124
| -2% | -$15.3K | 0.15% | 44 |
|
|
2023
Q4 | $625K | Sell |
5,732
-325
| -5% | -$33.7K | 0.13% | 48 |
|
|
2023
Q3 | $624K | Sell |
6,057
-5,390
| -47% | -$581K | 0.15% | 50 |
|
|
2023
Q2 | $1.32M | Sell |
11,447
-3,817
| -25% | -$433K | 0.3% | 34 |
|
|
2023
Q1 | $1.62M | Sell |
15,264
-1,607
| -10% | -$174K | 0.39% | 30 |
|
|
2022
Q4 | $1.87M | Sell |
16,871
-3,785
| -18% | -$387K | 0.48% | 27 |
|
|
2022
Q3 | $1.78M | Sell |
20,656
-469
| -2% | -$41.9K | 0.45% | 32 |
|
|
2022
Q2 | $1.93M | Sell |
21,125
-269
| -1% | -$23.8K | 0.47% | 29 |
|
|
2022
Q1 | $1.75M | Sell |
21,394
-2,190
| -9% | -$173K | 0.39% | 38 |
|
|
2021
Q4 | $1.81M | Sell |
23,584
-431
| -2% | -$34.3K | 0.43% | 35 |
|
|
2021
Q3 | $1.8M | Sell |
24,015
-88
| -0.4% | -$6.69K | 0.43% | 33 |
|
|
2021
Q2 | $1.87M | Sell |
24,103
-10
| -0% | -$744 | 0.46% | 36 |
|
|
2021
Q1 | $1.77M | Buy |
24,113
+342
| +1% | +$25.2K | 0.45% | 35 |
|
|
2020
Q4 | $1.85M | Sell |
23,771
-1,539
| -6% | -$118K | 0.52% | 34 |
|
|
2020
Q3 | $2M | Buy |
25,310
+9,825
| +63% | +$770K | 0.66% | 34 |
|
|
2020
Q2 | $1.14M | Sell |
15,485
-1,229
| -7% | -$92.5K | 0.4% | 58 |
|
|
2020
Q1 | $1.23M | Sell |
16,714
-1,451
| -8% | -$114K | 0.53% | 49 |
|
|
2019
Q4 | $1.58M | Buy |
18,165
+1,214
| +7% | +$99.7K | 0.52% | 54 |
|
|
2019
Q3 | $1.36M | Sell |
16,951
-911
| -5% | -$73K | 0.48% | 64 |
|
|
2019
Q2 | $1.43M | Sell |
17,862
-1,217
| -6% | -$93.2K | 0.52% | 58 |
|
|
2019
Q1 | $1.51M | Sell |
19,079
-1,172
| -6% | -$87.7K | 0.57% | 50 |
|
|
2018
Q4 | $1.48M | Buy |
+20,251
| New | +$1.43M | 0.62% | 47 |
|
Other funds holding MRK
ECSS
Human Investing's MRK Position: Q2 2026 in Review
Human Investing increased its Merck (MRK) stake by 3.3% in Q2 2026, buying an estimated $12.5K and bringing the position to 3,385 shares worth $435K. The position accounts for 0.06% of the portfolio, ranked #69.
Human Investing first reported a position in MRK in Q4 2018 and has held it in 31 quarters since. The position peaked at $2M in Q3 2020. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Human Investing held 3,385 shares of Merck worth $435K as of Q2 2026.
- Human Investing bought 107 Merck shares in Q2 2026, an estimated $12.5K.
- Merck made up 0.06% of Human Investing's portfolio in Q2 2026, its #69 holding.
- Human Investing first reported a position in Merck in Q4 2018 and has held it in 31 quarters since.
- Human Investing's Merck position peaked at $2M in Q3 2020.
- 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Human Investing's 13F filing for Q2 2026, filed 20 Jul 2026.